oxidopamine has been researched along with Atrophy in 8 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Excerpt | Relevance | Reference |
---|---|---|
"The influence of embryonic mesencephalic, striatal and mesencephalic/striatal co-grafts on amphetamine- and apomorphine-induced rotation behaviour was assessed in a rat model of multiple system atrophy/striatonigral degeneration type using dopamine D1 ([3H]SCH23390) and D2 ([3H]spiperone) receptor and dopamine re-uptake ([3H]mazindol) autoradiography." | 7.70 | Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesenc ( Granata, R; Jenner, P; Laboyrie, P; Poewe, W; Puschban, Z; Quinn, NP; Scherfler, C; Wenning, GK, 2000) |
"The influence of embryonic mesencephalic, striatal and mesencephalic/striatal co-grafts on amphetamine- and apomorphine-induced rotation behaviour was assessed in a rat model of multiple system atrophy/striatonigral degeneration type using dopamine D1 ([3H]SCH23390) and D2 ([3H]spiperone) receptor and dopamine re-uptake ([3H]mazindol) autoradiography." | 3.70 | Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesenc ( Granata, R; Jenner, P; Laboyrie, P; Poewe, W; Puschban, Z; Quinn, NP; Scherfler, C; Wenning, GK, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Westphal, R | 1 |
Sumiyoshi, A | 1 |
Simmons, C | 1 |
Mesquita, M | 1 |
Wood, TC | 1 |
Williams, SC | 1 |
Vernon, AC | 1 |
Cash, D | 1 |
Kim, TW | 1 |
Moon, Y | 1 |
Kim, K | 1 |
Lee, JE | 1 |
Koh, HC | 1 |
Rhyu, IJ | 1 |
Kim, H | 1 |
Sun, W | 1 |
Sherren, N | 1 |
Pappas, BA | 1 |
Karagüzel, G | 1 |
Gedikoğlu, G | 1 |
Tanyel, FC | 1 |
Büyükpamukçu, N | 1 |
Hiçsönmez, A | 1 |
Rosenblad, C | 1 |
Kirik, D | 1 |
Devaux, B | 1 |
Moffat, B | 1 |
Phillips, HS | 1 |
Björklund, A | 1 |
Puschban, Z | 1 |
Scherfler, C | 1 |
Granata, R | 1 |
Laboyrie, P | 1 |
Quinn, NP | 1 |
Jenner, P | 1 |
Poewe, W | 1 |
Wenning, GK | 1 |
Roghani, M | 1 |
Behzadi, G | 1 |
Finch, CE | 1 |
Kohama, SG | 1 |
Pasinetti, GM | 1 |
1 review available for oxidopamine and Atrophy
Article | Year |
---|---|
Ovarian steroid and neurotoxin models of brain aging in rodents.
Topics: Aging; Animals; Atrophy; Brain; Estrogens; Female; Mice; Mice, Inbred C57BL; Neurons; Neurotoxins; O | 1992 |
7 other studies available for oxidopamine and Atrophy
Article | Year |
---|---|
Characterization of gray matter atrophy following 6-hydroxydopamine lesion of the nigrostriatal system.
Topics: Animals; Apomorphine; Atrophy; Brain; Dopamine Agonists; Dopaminergic Neurons; Functional Laterality | 2016 |
Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson's diseases.
Topics: Animals; Apoptosis; Apoptosis Inducing Factor; Atrophy; bcl-2-Associated X Protein; Disease Models, | 2011 |
Selective acetylcholine and dopamine lesions in neonatal rats produce distinct patterns of cortical dendritic atrophy in adulthood.
Topics: Acetylcholine; Animals; Animals, Newborn; Antibodies, Monoclonal; Atrophy; Body Weight; Brain Chemis | 2005 |
Subsequent biological effects of chemical sympathectomy in rats undergoing unilateral testicular torsion.
Topics: Animals; Atrophy; Female; Fertility; Male; Necrosis; Oxidopamine; Pregnancy; Random Allocation; Rats | 1995 |
Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
Topics: Amphetamine; Animals; Antibodies; Apomorphine; Atrophy; Body Weight; Cerebral Ventricles; Corpus Str | 1999 |
Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesenc
Topics: Amphetamine; Animals; Apomorphine; Atrophy; Autoradiography; Behavior, Animal; Brain Tissue Transpla | 2000 |
Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence.
Topics: Amphetamine; Animals; Apomorphine; Atrophy; Axonal Transport; Corpus Striatum; Disease Models, Anima | 2001 |